EBGLYSS

What is this medication? EBGLYSS is a prescription medicine used to treat adults and children 12 years of age and older who suffer from moderate-to-severe atopic dermatitis, commonly referred to as eczema. This medication is specifically intended for patients whose condition is not adequately controlled with topical prescription therapies, such as creams or ointments, or for those who cannot use those types of treatments. It is administered as an injection under the skin to help manage the persistent skin inflammation and intense itching associated with the condition.

The active ingredient in EBGLYSS is lebrikizumab-lbkz, which functions as an interleukin-13 antagonist. By targeting and blocking this specific protein in the immune system, the medication helps to interrupt the underlying inflammatory process that leads to the redness, dryness, and skin irritation characteristic of atopic dermatitis. It can be used as a standalone treatment or in combination with topical corticosteroids, depending on the guidance and treatment plan provided by a healthcare professional.